The study will target patients scheduled for knee or hip arthroplasty who have been diagnosed with insomnia and are taking lemborexant. The primary objective will be to determine whether lemborexant can be taken throughout the perioperative period (lemborexant intake rate), with secondary objectives to determine changes in sleep efficiency, the proportion of patients who used sleeping pills and tranquilizers other than lemborexant during the perioperative period, and the degree of postoperative
Conditions
Interventions
None listed
Sponsors
Nara Medical University
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: The study will target patients who are scheduled for knee or hip arthroplasty, have been diagnosed with insomnia, and are taking lemborexant.
Exclusion criteria
Exclusion criteria: Patients taking hypnotics or antipsychotics other than lemborexant at the time of anesthesiology consultation
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Rate of taking lemborexant | — |
Countries
Japan
Contacts
Public ContactIda Mitsuru
Nara Medical University Anesthesiology
Outcome results
None listed